Table of Contents 1 Pancreatic Beta-Cell Protection Market Overview 1.1 Product Overview and Scope of Pancreatic Beta-Cell Protection 1.2 Classification of Pancreatic Beta-Cell Protection by Type 1.2.1 Global Pancreatic Beta-Cell Protection Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Type in 2019 1.2.3 Stem Cell Based 1.2.4 Gene Therapies 1.2.5 RNA Based Therapies 1.2.6 Monoclonal Antibodies (MAbs) 1.2.7 Phytotherapy 1.3 Global Pancreatic Beta-Cell Protection Market by Application 1.3.1 Overview: Global Pancreatic Beta-Cell Protection Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospital 1.3.3 Medical Research Laboratory 1.3.4 Others 1.4 Global Pancreatic Beta-Cell Protection Market by Regions 1.4.1 Global Pancreatic Beta-Cell Protection Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Pancreatic Beta-Cell Protection (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025) 2 Company Profiles 2.1 ViaCyte 2.1.1 ViaCyte Details 2.1.2 ViaCyte Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 ViaCyte SWOT Analysis 2.1.4 ViaCyte Product and Services 2.1.5 ViaCyte Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.2 Pfizer Inc 2.2.1 Pfizer Inc Details 2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Pfizer Inc SWOT Analysis 2.2.4 Pfizer Inc Product and Services 2.2.5 Pfizer Inc Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.3 GalaxoSmithKline 2.3.1 GalaxoSmithKline Details 2.3.2 GalaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 GalaxoSmithKline SWOT Analysis 2.3.4 GalaxoSmithKline Product and Services 2.3.5 GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.4 PharmaCyte Biotech 2.4.1 PharmaCyte Biotech Details 2.4.2 PharmaCyte Biotech Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 PharmaCyte Biotech SWOT Analysis 2.4.4 PharmaCyte Biotech Product and Services 2.4.5 PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.5 Janssen Research & Development 2.5.1 Janssen Research & Development Details 2.5.2 Janssen Research & Development Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Janssen Research & Development SWOT Analysis 2.5.4 Janssen Research & Development Product and Services 2.5.5 Janssen Research & Development Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.6 Boehringer Ingelheim 2.6.1 Boehringer Ingelheim Details 2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Boehringer Ingelheim SWOT Analysis 2.6.4 Boehringer Ingelheim Product and Services 2.6.5 Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.7 Genentech 2.7.1 Genentech Details 2.7.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Genentech SWOT Analysis 2.7.4 Genentech Product and Services 2.7.5 Genentech Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.8 Novartis 2.8.1 Novartis Details 2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Novartis SWOT Analysis 2.8.4 Novartis Product and Services 2.8.5 Novartis Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.9 Beta-Cell NV 2.9.1 Beta-Cell NV Details 2.9.2 Beta-Cell NV Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Beta-Cell NV SWOT Analysis 2.9.4 Beta-Cell NV Product and Services 2.9.5 Beta-Cell NV Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.10 BioLineRx 2.10.1 BioLineRx Details 2.10.2 BioLineRx Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 BioLineRx SWOT Analysis 2.10.4 BioLineRx Product and Services 2.10.5 BioLineRx Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.11 Transition Therapeutics 2.11.1 Transition Therapeutics Details 2.11.2 Transition Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 Transition Therapeutics SWOT Analysis 2.11.4 Transition Therapeutics Product and Services 2.11.5 Transition Therapeutics Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.12 Novo Nordisk 2.12.1 Novo Nordisk Details 2.12.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Novo Nordisk SWOT Analysis 2.12.4 Novo Nordisk Product and Services 2.12.5 Novo Nordisk Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.13 Beta-O2 Technologies Ltd 2.13.1 Beta-O2 Technologies Ltd Details 2.13.2 Beta-O2 Technologies Ltd Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 Beta-O2 Technologies Ltd SWOT Analysis 2.13.4 Beta-O2 Technologies Ltd Product and Services 2.13.5 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.14 Sanofi 2.14.1 Sanofi Details 2.14.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 Sanofi SWOT Analysis 2.14.4 Sanofi Product and Services 2.14.5 Sanofi Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 2.15 Osiris Therapeutics 2.15.1 Osiris Therapeutics Details 2.15.2 Osiris Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis 2.15.3 Osiris Therapeutics SWOT Analysis 2.15.4 Osiris Therapeutics Product and Services 2.15.5 Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Pancreatic Beta-Cell Protection Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Pancreatic Beta-Cell Protection Players Market Share 3.2.2 Top 10 Pancreatic Beta-Cell Protection Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Pancreatic Beta-Cell Protection Revenue and Market Share by Regions 4.2 North America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 4.3 Europe Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 4.5 South America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 5 North America Pancreatic Beta-Cell Protection Revenue by Countries 5.1 North America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) 5.2 USA Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 5.3 Canada Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 5.4 Mexico Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 6 Europe Pancreatic Beta-Cell Protection Revenue by Countries 6.1 Europe Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) 6.2 Germany Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 6.3 UK Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 6.4 France Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 6.5 Russia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 6.6 Italy Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Pancreatic Beta-Cell Protection Revenue by Countries 7.1 Asia-Pacific Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) 7.2 China Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 7.3 Japan Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 7.4 Korea Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 7.5 India Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 8 South America Pancreatic Beta-Cell Protection Revenue by Countries 8.1 South America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) 8.2 Brazil Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 8.3 Argentina Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Pancreatic Beta-Cell Protection by Countries 9.1 Middle East & Africa Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) 9.2 Saudi Arabia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 9.3 UAE Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 9.4 Egypt Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 9.5 South Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Pancreatic Beta-Cell Protection Revenue and Market Share by Type (2015-2020) 10.2 Global Pancreatic Beta-Cell Protection Market Forecast by Type (2019-2024) 10.3 Stem Cell Based Revenue Growth Rate (2015-2025) 10.4 Gene Therapies Revenue Growth Rate (2015-2025) 10.5 RNA Based Therapies Revenue Growth Rate (2015-2025) 10.6 Monoclonal Antibodies (MAbs) Revenue Growth Rate (2015-2025) 10.7 Phytotherapy Revenue Growth Rate (2015-2025) 11 Global Pancreatic Beta-Cell Protection Market Segment by Application 11.1 Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2015-2020) 11.2 Pancreatic Beta-Cell Protection Market Forecast by Application (2019-2024) 11.3 Hospital Revenue Growth (2015-2020) 11.4 Medical Research Laboratory Revenue Growth (2015-2020) 11.5 Others Revenue Growth (2015-2020) 12 Global Pancreatic Beta-Cell Protection Market Size Forecast (2021-2025) 12.1 Global Pancreatic Beta-Cell Protection Market Size Forecast (2021-2025) 12.2 Global Pancreatic Beta-Cell Protection Market Forecast by Regions (2021-2025) 12.3 North America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) 12.4 Europe Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) 12.6 South America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Pancreatic Beta-Cell Protection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Pancreatic Beta-Cell Protection by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Pancreatic Beta-Cell Protection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Pancreatic Beta-Cell Protection Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. ViaCyte Corporate Information, Location and Competitors Table 6. ViaCyte Pancreatic Beta-Cell Protection Major Business Table 7. ViaCyte Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 8. ViaCyte SWOT Analysis Table 9. ViaCyte Pancreatic Beta-Cell Protection Product and Solutions Table 10. ViaCyte Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 11. Pfizer Inc Corporate Information, Location and Competitors Table 12. Pfizer Inc Pancreatic Beta-Cell Protection Major Business Table 13. Pfizer Inc Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2018-2019) Table 14. Pfizer Inc SWOT Analysis Table 15. Pfizer Inc Pancreatic Beta-Cell Protection Product and Solutions Table 16. Pfizer Inc Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 17. GalaxoSmithKline Corporate Information, Location and Competitors Table 18. GalaxoSmithKline Pancreatic Beta-Cell Protection Major Business Table 19. GalaxoSmithKline Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 20. GalaxoSmithKline SWOT Analysis Table 21. GalaxoSmithKline Pancreatic Beta-Cell Protection Product and Solutions Table 22. GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 23. PharmaCyte Biotech Corporate Information, Location and Competitors Table 24. PharmaCyte Biotech Pancreatic Beta-Cell Protection Major Business Table 25. PharmaCyte Biotech Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 26. PharmaCyte Biotech SWOT Analysis Table 27. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product and Solutions Table 28. PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 29. Janssen Research & Development Corporate Information, Location and Competitors Table 30. Janssen Research & Development Pancreatic Beta-Cell Protection Major Business Table 31. Janssen Research & Development Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 32. Janssen Research & Development SWOT Analysis Table 33. Janssen Research & Development Pancreatic Beta-Cell Protection Product and Solutions Table 34. Janssen Research & Development Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 35. Boehringer Ingelheim Corporate Information, Location and Competitors Table 36. Boehringer Ingelheim Pancreatic Beta-Cell Protection Major Business Table 37. Boehringer Ingelheim Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 38. Boehringer Ingelheim SWOT Analysis Table 39. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product and Solutions Table 40. Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 41. Genentech Corporate Information, Location and Competitors Table 42. Genentech Pancreatic Beta-Cell Protection Major Business Table 43. Genentech Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 44. Genentech SWOT Analysis Table 45. Genentech Pancreatic Beta-Cell Protection Product and Solutions Table 46. Genentech Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 47. Novartis Corporate Information, Location and Competitors Table 48. Novartis Pancreatic Beta-Cell Protection Major Business Table 49. Novartis Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 50. Novartis SWOT Analysis Table 51. Novartis Pancreatic Beta-Cell Protection Product and Solutions Table 52. Novartis Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 53. Beta-Cell NV Corporate Information, Location and Competitors Table 54. Beta-Cell NV Pancreatic Beta-Cell Protection Major Business Table 55. Beta-Cell NV Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 56. Beta-Cell NV SWOT Analysis Table 57. Beta-Cell NV Pancreatic Beta-Cell Protection Product and Solutions Table 58. Beta-Cell NV Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 59. BioLineRx Corporate Information, Location and Competitors Table 60. BioLineRx Pancreatic Beta-Cell Protection Major Business Table 61. BioLineRx Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 62. BioLineRx SWOT Analysis Table 63. BioLineRx Pancreatic Beta-Cell Protection Product and Solutions Table 64. BioLineRx Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 65. Transition Therapeutics Corporate Information, Location and Competitors Table 66. Transition Therapeutics Pancreatic Beta-Cell Protection Major Business Table 67. Transition Therapeutics Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 68. Transition Therapeutics SWOT Analysis Table 69. Transition Therapeutics Pancreatic Beta-Cell Protection Product and Solutions Table 70. Transition Therapeutics Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 71. Novo Nordisk Corporate Information, Location and Competitors Table 72. Novo Nordisk Pancreatic Beta-Cell Protection Major Business Table 73. Novo Nordisk Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 74. Novo Nordisk SWOT Analysis Table 75. Novo Nordisk Pancreatic Beta-Cell Protection Product and Solutions Table 76. Novo Nordisk Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 77. Beta-O2 Technologies Ltd Corporate Information, Location and Competitors Table 78. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Major Business Table 79. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 80. Beta-O2 Technologies Ltd SWOT Analysis Table 81. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product and Solutions Table 82. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 83. Sanofi Corporate Information, Location and Competitors Table 84. Sanofi Pancreatic Beta-Cell Protection Major Business Table 85. Sanofi Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 86. Sanofi SWOT Analysis Table 87. Sanofi Pancreatic Beta-Cell Protection Product and Solutions Table 88. Sanofi Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 89. Osiris Therapeutics Corporate Information, Location and Competitors Table 90. Osiris Therapeutics Pancreatic Beta-Cell Protection Major Business Table 91. Osiris Therapeutics Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018) Table 92. Osiris Therapeutics SWOT Analysis Table 93. Osiris Therapeutics Pancreatic Beta-Cell Protection Product and Solutions Table 94. Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 95. Global Pancreatic Beta-Cell Protection Revenue (Million USD) by Players (2015-2020) Table 96. Global Pancreatic Beta-Cell Protection Revenue Share by Players (2015-2020) Table 97. Global Pancreatic Beta-Cell Protection Revenue (Million USD) by Regions (2015-2020) Table 98. Global Pancreatic Beta-Cell Protection Revenue Market Share by Regions (2015-2020) Table 99. North America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) Table 100. North America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Table 101. Europe Pancreatic Beta-Cell Protection Revenue (Million USD) by Countries (2015-2020) Table 102. Asia-Pacific Pancreatic Beta-Cell Protection Revenue (Million USD) by Countries (2015-2020) Table 103. South America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020) Table 104. South America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Table 105. Middle East and Africa Pancreatic Beta-Cell Protection Revenue (Million USD) by Countries (2015-2020) Table 106. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Table 107. Global Pancreatic Beta-Cell Protection Revenue (Million USD) by Type (2015-2020) Table 108. Global Pancreatic Beta-Cell Protection Revenue Share by Type (2015-2020) Table 109. Global Pancreatic Beta-Cell Protection Revenue Forecast by Type (2021-2025) Table 110. Global Pancreatic Beta-Cell Protection Revenue by Application (2015-2020) Table 111. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2015-2020) Table 112. Global Pancreatic Beta-Cell Protection Revenue Forecast by Application (2021-2025) Table 113. Global Pancreatic Beta-Cell Protection Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Pancreatic Beta-Cell Protection Picture Figure 2. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type in 2019 Figure 3. Stem Cell Based Picture Figure 4. Gene Therapies Picture Figure 5. RNA Based Therapies Picture Figure 6. Monoclonal Antibodies (MAbs) Picture Figure 7. Phytotherapy Picture Figure 8. Pancreatic Beta-Cell Protection Revenue Market Share by Application in 2019 Figure 9. Hospital Picture Figure 10. Medical Research Laboratory Picture Figure 11. Others Picture Figure 12. Global Pancreatic Beta-Cell Protection Revenue (USD Million) and Growth Rate (2015-2025) Figure 13. North America Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025) Figure 14. Europe Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025) Figure 15. Asia-Pacific Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025) Figure 16. South America Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025) Figure 17. Middle East and Africa Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025) Figure 18. Global Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025) Figure 19. Global Pancreatic Beta-Cell Protection Revenue Share by Players in 2019 Figure 20. Global Top 5 Players Pancreatic Beta-Cell Protection Revenue Market Share in 2019 Figure 21. Global Top 10 Players Pancreatic Beta-Cell Protection Revenue Market Share in 2019 Figure 22. Key Players Market Share Trend Figure 23. Global Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 24. Global Pancreatic Beta-Cell Protection Revenue Market Share by Regions (2015-2020) Figure 25. Global Pancreatic Beta-Cell Protection Revenue Market Share by Regions in 2018 Figure 26. North America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 27. Europe Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 28. Asia-Pacific Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 29. South America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 30. Middle East and Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 31. North America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Figure 32. North America Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019 Figure 33. USA Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 34. Canada Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 35. Mexico Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 36. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Figure 37. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019 Figure 38. Germany Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 39. UK Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 40. France Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 41. Russia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 42. Italy Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 43. Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Figure 44. Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019 Figure 45. China Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 46. Japan Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 47. Korea Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 48. India Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 49. Southeast Asia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 50. South America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Figure 51. South America Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019 Figure 52. Brazil Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 53. Argentina Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 54. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020) Figure 55. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019 Figure 56. Saudi Arabia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 57. UAE Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 58. Egypt Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 59. South Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020) Figure 60. Global Pancreatic Beta-Cell Protection Revenue Share by Type (2015-2020) Figure 61. Global Pancreatic Beta-Cell Protection Revenue Share by Type in 2019 Figure 62. Global Pancreatic Beta-Cell Protection Market Share Forecast by Type (2021-2025) Figure 63. Global Stem Cell Based Revenue Growth Rate (2015-2020) Figure 64. Global Gene Therapies Revenue Growth Rate (2015-2020) Figure 65. Global RNA Based Therapies Revenue Growth Rate (2015-2020) Figure 66. Global Monoclonal Antibodies (MAbs) Revenue Growth Rate (2015-2020) Figure 67. Global Phytotherapy Revenue Growth Rate (2015-2020) Figure 68. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2015-2020) Figure 69. Global Pancreatic Beta-Cell Protection Revenue Share by Application in 2019 Figure 70. Global Pancreatic Beta-Cell Protection Market Share Forecast by Application (2021-2025) Figure 71. Global Hospital Revenue Growth Rate (2015-2020) Figure 72. Global Medical Research Laboratory Revenue Growth Rate (2015-2020) Figure 73. Global Others Revenue Growth Rate (2015-2020) Figure 74. Global Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 75. Global Pancreatic Beta-Cell Protection Revenue (Million USD) Forecast by Regions (2021-2025) Figure 76. Global Pancreatic Beta-Cell Protection Revenue Market Share Forecast by Regions (2021-2025) Figure 77. North America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) Figure 78. Europe Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) Figure 79. Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) Figure 80. South America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) Figure 81. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025) Figure 82. Sales Channel: Direct Channel vs Indirect Channel

ViaCyte Pfizer Inc GalaxoSmithKline PharmaCyte Biotech Janssen Research & Development Boehringer Ingelheim Genentech Novartis Beta-Cell NV BioLineRx Transition Therapeutics Novo Nordisk Beta-O2 Technologies Ltd Sanofi Osiris Therapeutics